Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Evguenia Lindgardt M.B.A. | President, CEO & Director | 622.42k | -- | 1975 |
| Mr. Austin Aerts | Chief Financial Officer | 367.62k | -- | 1988 |
| Dr. John J. Boniface Ph.D. | Chief Scientific Officer | 467.32k | -- | 1963 |
| Dr. Gregory C. Critchfield M.D., M.S. | Executive Director | 1.04M | -- | 1953 |
| Mr. Robert G. Harrison | Chief Information Officer | 384.18k | -- | 1966 |
| Mr. Benjamin G. Jackson J.D. | General Counsel | 410.75k | -- | 1980 |
| Dr. Paul Kearney Ph.D. | Chief Data Officer | -- | -- | 1969 |
Sera Prognostics, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 63
Description
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 9, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission